Reprogramming immune cells for living cancer therapy

Possible biological explanation for increased cancer risk in dense breasts

Lamin C facilitates repair of damaged nuclear envelope in human and mouse cells

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported